RFK Launches Investigation into Over Prescription of Amphetamines, SSRIs to Our Kids

The Trump administration has launched an investigation into the over-prescription of amphetamines and psychotropic drugs to children. Health and Human Services Secretary Robert F. Kennedy Jr. is leading the effort, sparking debate over the role of pharmaceuticals in youth mental health treatment.

Key Facts:

President Trump established the Make America Health Again Commission to assess the overuse of pharmaceuticals in children.
Health and Human Services Secretary Robert F. Kennedy Jr. is leading the investigation, focusing on antidepressants, ADHD medication, and other psychotropic drugs.
A 2024 study found that antidepressant prescriptions for 12- to 17-year-olds increased by 43% between 2016 and 2022, rising even faster after COVID-19.
ADHD medications, primarily amphetamines, are widely prescribed, with 15% of American youth reportedly taking them.
The medical establishment is divided, with some psychiatrists concerned about losing access to these drugs while others acknowledge the risks of overmedication.

The Rest of The Story:

President Trump has directed Robert F. Kennedy Jr. to investigate the impact of pharmaceuticals on children, including potential overprescription and harmful side effects.

This initiative is part of a broader effort to restore public confidence in the medical system, which has been under scrutiny since the COVID-19 pandemic.

Kennedy has long been vocal about the dangers of widespread medication use, arguing that America is overmedicating its youth.

RFK Jr. on Overprescription: 'All the People Defending Pharma Profits, Including Senators Taking Millions, Are Not Making Our Country Healthier'

"Today, 15% of American kids are on Adderall. And, there's clearly a major problem with overprescription, not just with our children,… pic.twitter.com/DXFbwLdGWU

— Camus (@newstart_2024) January 30, 2025

Studies show a sharp rise in antidepressant prescriptions for teenagers, and concerns over ADHD overdiagnosis have persisted for years.

Some medical professionals argue that restricting access to these medications could harm children with legitimate mental health needs.

However, others believe these drugs are being handed out too freely, leading to dependency and long-term health risks.

The Trump administration’s move has prompted debate, with critics accusing them of politicizing healthcare, while supporters see it as a necessary step toward reining in Big Pharma’s influence over children’s health.

Commentary:

For decades, the pharmaceutical industry has benefited from the overprescription of psychotropic drugs, particularly to children.

The rise in ADHD diagnoses has coincided with an explosion in amphetamine prescriptions, creating a generation of kids dependent on stimulant medication.

The trend only worsened after COVID-19, with a sharp increase in antidepressant use.

It’s not unreasonable to question whether children are being medicated to fit into a system rather than receiving real, lasting treatment for their challenges.

SSRIs, often prescribed for depression and anxiety, come with withdrawal symptoms that resemble addiction.

The claim that they aren’t addictive is misleading, as anyone who has tried to quit these medications can attest.

Meanwhile, amphetamines—known to be highly addictive—are handed out to millions of kids.

The long-term effects of these drugs on developing brains remain unclear, yet they are prescribed at record rates.

The medical establishment, with its deep ties to the pharmaceutical industry, will likely push back against any attempts to cut back on these prescriptions.

🚨 JUST IN: RFK Jr. says he won’t hesitate to investigate “taboo” topics like the childhood vaccine schedule, electromagnetic radiation, glyphosate, other pesticides, ultra processed foods, artificial food additives, SSRI and other psychiatric drugs.

“Nothing is gonna be… pic.twitter.com/TpwlbFFtgg

— Lauren Lee (@sheislaurenlee) February 18, 2025

Billions of dollars are at stake, and drug companies have a vested interest in maintaining the status quo.

However, if America is serious about its children’s health, it must explore alternatives, including therapy, lifestyle changes, and other holistic approaches.

Parents should be asking whether these medications are truly necessary or if they’re just an easy solution for a deeper problem.

Instead of continuing down this path, policymakers and healthcare professionals should work to develop strategies to reduce children’s dependence on these drugs.

The Bottom Line:

The Trump administration’s investigation into the overmedication of children is long overdue.

With amphetamines and antidepressants being prescribed at record levels, it’s critical to examine their long-term effects and seek alternative treatments.

The pharmaceutical industry stands to lose billions, which explains its resistance, but America’s children deserve better than being a captive market for Big Pharma.